Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBO2 vs Trental/Vitamin E for Post-Radiation Fibrosis
NCT03916068Phase 2Terminated
- Sponsor
- Legacy Health
- Start
- Jul 2019
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Legacy Health. Primary endpoint: Change in breast fibrosis using Bakers Grade Assessment at 157 weeks. Started Jul 2019; status: terminated.
Beyond the preview
Go deeper on NCT03916068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03916068.